Clinical Trials Logo

Clinical Trial Summary

Peripheral intravenous cannulas (PIVCs) are utilized in large scale in modern health care. Known complications due to a PIVC are phlebitis, thrombosis, bleeding, nerve damage and infection. PIVC-related infection causes morbidity, mortality and increased healthcare costs. PIVC-related infections can and should be prevented.

Indwell time is a known risk factor for PIVC-related infection. Another factor potentially influencing the risk of developing PIVC-related infection is what type of PIVC that is being used. Roughly there are two types of PIVCs. One with an open injection valve and another with a closed injection valve. The former being far more used in our hospital and the latter being suggested as lowering the risk of PIVC-related infection compared to the open one.

The investigators aim with this study is to evaluate the incidence of PIVC-colonization in 300 patients at our 500-bed secondary level hospital in Sweden, as a first step in trying to understand what healthcare-providers can improve regarding prevention of PIVC-related infections.


Clinical Trial Description

Background:

Peripheral intravenous cannulas (PIVCs) are utilized in large scale in modern health care. Known complications due to a PIVC are phlebitis, thrombosis, bleeding, nerve damage and infection. PIVC-related infection causes morbidity, mortality and increased healthcare costs. In an Australian study the investigators found the presence of a PIVC the most frequent cause (36%) of healthcare-associated Staphylococcus aureus bacteraemia during 2012. PIVC-related infections can and should be prevented.

Indwell time is a known risk factor for PIVC-related infection. Another factor potentially influencing the risk of developing PIVC-related infection is what type of PIVC that is being used. Roughly there are two types of PIVCs. One with an open injection valve and another with a closed injection valve. The former being far more used in Ryhov County Hospital, Sweden, and the latter being suggested as lowering the risk of PIVC-related infection compared to the open one.

In a systematic review from 2006 Maki et al report a point incidence of blood stream infections of 0,5 per 1000 catheter-days in PIVCs. In 2014 Hammarskjöld reported an incidence of 0,6 per 1000 catheter-days regarding central venous catheters (CVC). Maki et al concludes "…, infection control programs must strive to consistently apply essential control measures and preventive technologies with all types of intravascular devices." The investigators find there is a gap between the large scale utilization of PIVCs and the knowledge about PIVC-related infections and recommendations on how to prevent them. Hammarskjöld et al has done research on infections related to CVCs, subcutaneous venous ports and on arterial cannulas but not PIVCs.

The aim with this study is to evaluate the incidence of PIVC-colonization at Ryhov County Hospital, a 500-bed secondary level hospital in Sweden, as a first step in trying to understand what can be done to improve work regarding prevention of PIVC-related infections.

Materials and methods

Setting The hospital is a 500-bed general county hospital including most medical, oncological and surgical specialties except neurosurgery and cardiac surgery. No solid organ or stem cell transplantations are performed.

Patients Patients admitted to surgical, medical or infectious wards were regularly included by a specifically trained nurse from June 2016 until December 2017.

Inclusion criteria: Patients ≥ 18 years of age with a PIVC in situ for 48 hours or more informed verbally and in written and invited to take part in the study. Exclusion criteria: Patients < 18 years of age.

Microbiological methods Intraluminal hub culturing from the two injection sites of the PIVC performed with sterile cotton-tipped applicators moistened with sterile sodium chloride 0,9 %. Swabs transported in Amies medium with charcoal. Identification performed by standard methods at our local microbiology laboratory (www.srga.org.accessed _ http:// www.srga.org.accessed/ _ January 1, 2007).

Statistics Descriptive. How many positive cultures and which type of microbes were found. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03351725
Study type Observational
Source Linkoeping University
Contact
Status Completed
Phase
Start date June 2016
Completion date December 20, 2017

See also
  Status Clinical Trial Phase
Terminated NCT04787926 - DuraLock-C Catheter Lock Solution
Active, not recruiting NCT02515201 - Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children Phase 4
Recruiting NCT04140916 - Comparison of Two Peripheral Inserted Intravenous Catheters N/A
Not yet recruiting NCT06019897 - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed NCT02970409 - Heparin Versus Saline in Peripheral Venous Catheter N/A
Completed NCT03101371 - Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion Phase 2
Completed NCT04821193 - Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to Catheter N/A
Completed NCT04155723 - Impact of a Task Delegation to ICU Nurses for Midlines' Placement
Completed NCT02577718 - Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution Phase 1/Phase 2
Completed NCT02279121 - ATAPAC Study (TauroLock Activity in Adult Cancer Patients) N/A
Completed NCT00965198 - Comparison of Infection Rates Among Patients Using Two Catheter Access Devices N/A
Recruiting NCT05741866 - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) N/A
Recruiting NCT04825314 - Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization N/A
Active, not recruiting NCT03945045 - A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD N/A
Active, not recruiting NCT01592032 - Concentration of Antimicrobials in Catheter-lock Solutions Phase 4
Terminated NCT04906512 - Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy N/A
Withdrawn NCT02899780 - Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light N/A
Recruiting NCT05995080 - The Effectiveness of Chlorhexidine Gluconate on Prevention of Catheter-Related Bloodstream Infections N/A
Completed NCT04794231 - Comparison of Chlorhexidine Impregnated Dressing and Standard Dressing N/A
Terminated NCT03447639 - Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal Phase 4